Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.85 |
| ▸ | POLB | P06746 | 1/20 | 0.85 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2328687 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL4068798 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL4070067 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL25267924 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL5165082 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL25270261 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL25240227 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL25267373 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL634872 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL363481 | 1.00 | ALDH1A1 (0.85) | ALDH1A1KMT2APOLBTLR8CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114315728-B | Imidazole ionic liquid and application thereof in alcoholysis polymerization of 2, 5-furandicarboxylic acid ester | 中国科学院大连化学物理研究所 | 2024-04-19 | — | — | CN | disclosed |
| US-11419335-B2 | N-arylated analogues and uses thereof | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2022-08-23 | — | — | US | disclosed |
| WO-2018106922-A1 | N-ARYLATED ANALOGUES AND USES THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2018-06-14 | — | — | WO | disclosed |
| CN-107413386-A | A kind of catalyst of methanol liquid phase one-step oxidation to methylal and preparation method thereof and application method | 中国科学院成都有机化学有限公司 | 2017-12-01 | — | — | CN | disclosed |
| EP-2474527-B1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEM IND LTD (JP) | 2017-01-25 | — | — | EP | disclosed |
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| WO-2009040107-A2 | METHOD FOR THE PRODUCTION OF METAL-CONTAINING NANOPARTICLES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009024312-A2 | METHOD FOR THE PRODUCTION AND STABILIZATION OF FUNCTIONAL METAL NANOPARTICLES IN IONIC LIQUIDS | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-02-26 | — | — | WO | disclosed |
| US-4140518-A | IMIDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1979-02-20 | — | — | US | disclosed |
| US-4062965-A | Quaternary imidazole compounds as microbicides | TH. GOLDSCHMIDT AG (DT) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11419335-B2 | N-arylated analogues and uses thereof | CFTR, UGT1A1, NAT1 | ALDH1A1 691/4885KMT2A 4201/4885POLB 2282/4885 |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | ALDH1A1 3717/4885KMT2A 4633/4885POLB 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.